Immunotherapy for cancer treatment is the new innovative
and effective treatment for future generations..unfortunately
cancer is increasing in all age groups, and there are
many pharmas offering cancer drugs which may soon
have patent expiry and so will be ongoing demand for
best replacement therapies. I am aware that Imugene has
competition in this field, but so far it has performed
outstandingly and would be a financial boon to a supplier.
It is hard to see that its performance could be overlooked
and have come to understand that there are many paths
that may lead to commercialisation. Some shareholders
may be seeking quick returns but those who are patient
will profit from their wait.
- Forums
- ASX - By Stock
- Ann: Imugene Receives Orphan Drug Designation for VAXINIA
Immunotherapy for cancer treatment is the new innovativeand...
-
- There are more pages in this discussion • 214 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M |
Open | High | Low | Value | Volume |
4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 3429444 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 149299 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 3075363 | 0.049 |
95 | 13038145 | 0.048 |
58 | 6515985 | 0.047 |
30 | 3952036 | 0.046 |
51 | 4977166 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 149299 | 2 |
0.051 | 1149798 | 7 |
0.052 | 1191692 | 8 |
0.053 | 1765338 | 11 |
0.054 | 2857321 | 12 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |